Publications
32
Citations
266
Est. group size
—
Recurring co-author estimate
Active years
10
Publishing since 2016
Yujin Park conducts biomedical research spanning several areas, with a notable focus on finding and testing drugs against Mycobacterium abscessus, a difficult-to-treat bacterial infection. Other work includes tuberculosis detection in kidney-disease patients, environmental toxicology using zebrafish to study how chemicals disrupt hormones, and digital health tools for managing diabetes.
Publication activity grew through the early 2020s, peaking around 2022, and has remained fairly steady at roughly 3-5 papers per year since.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Disruption of Thyroid and Sex Hormones, Lipid Metabolism, and Neurobehavior by Trioctyl Trimellitate (TOTM) in Larval and Adult Zebrafish
SSRN Electronic Journal · 2025
- Disruption of Thyroid and Sex Hormones, Lipid Metabolism, and Neurobehavior by Trioctyl Trimellitate (TOTM) in Larval and Adult Zebrafish
SSRN Electronic Journal · 2025
- Subchronic exposure to four organic UV filters disrupted thyroid endocrine and neuronal systems in zebrafish: Insights into underlying toxicological mechanisms at different life stages
Journal of Hazardous Materials · 2025
- Impact of real-time continuous glucose monitoring and personalized digital health coaching on glycemic control and lifestyle in patients with type 2 diabetes and prediabetes
Primary care diabetes · 2025
- Interferon-Gamma Release Assay Combined with Renal Indicators to Reduce the False-Negativity of Latent Tuberculosis Infection in End-Stage Renal Disease with Hemodialysis Patients
Discovery Medicine · 2024
- DS86760016, a Leucyl-tRNA Synthetase Inhibitor, Is Active against Mycobacterium abscessus
Antimicrobial Agents and Chemotherapy · 2023
- CRISPR Interference-Based Inhibition of MAB_0055c Expression Alters Drug Sensitivity in Mycobacterium abscessus
Microbiology Spectrum · 2023
- Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
Frontiers in Pharmacology · 2021
- A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus
International Journal of Molecular Sciences · 2021
- Corrigendum to “Controlled release of NELL-1 protein from chitosan/hydroxyapatite-modified TCP particles” [Int. J. Pharmaceut. 511(1) (2016) 79–89]
International Journal of Pharmaceutics · 2019
- Aronia Extract Lowers Porcine Pancreatic Lipase Activity In Vitro
한국식품영양과학회 학술대회발표집 · 2016
- Controlled release of NELL-1 protein from chitosan/hydroxyapatite-modified TCP particles
International Journal of Pharmaceutics · 2016
- Frontiers in Immunology×3
- Research Square×3
- Transplantation×3
- ASAIO Journal×2
- American Journal Of Pathology×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile